New number of shares and votes in Moberg Pharma AB (publ)
Moberg Pharma AB (publ) (the “Company”) today announces that the number of ordinary shares in the Company has increased to a total of 47,016,521 due to the exercise of warrants of series 2023:1 (“TO 2”) and due to the issue of C-shares which subsequently were converted into ordinary shares and repurchased by the Company to secure the Company's commitments under incentive programmes.The issue of the C-shares which subsequently were converted into ordinary shares has entailed an increase in the number of ordinary shares and votes of 832,213. The exercise of TO 2 has entailed an increase in